Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| TScan Therapeutics, Inc.(TCRX) | 630,000 | 630,000 | 0 | $3.14M | $1.92M | 53.75% | -$1.22M |
| Werewolf Therapeutics, Inc.(HOWL) | 589,102 | 589,102 | 0 | $1.25M | $871.9K | 24.47% | -$377.0K |
| Barinthus Biotherapeutics PlADS | 642,204 | 642,204 | 0 | $764.2K | $775.8K | 21.77% | +$11.6K |